Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 4 Randomized Multicentric Controlled Study on Impact of Continuous Venovenous Hemofiltration on Organ Failure at the Early Phase of Severe Sepsis

NCT00406198 is registered in ClinicalTrials.gov with Hopital Lariboisière as lead sponsor.

NCT NCT00406198
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00406198 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 4 Randomized Multicentric Controlled Study on Impact of Continuous Venovenous Hemofiltration on Organ Failure at the Early Phase of Severe Sepsis
Lead sponsor
Hopital Lariboisière
Phase
Phase 4
Overall status
Completed
Start date
March 31, 1997
Completion date
December 31, 1999
Enrollment
400
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bacteremia, gram-negative bacterial infections, gram-positive bacterial infections, pneumonia, bacterial, sepsis, shock, septic